Fusion Pharmaceuticals Inc. Purchase Agreements

9 Contracts & Agreements
Recent Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
Amendment No. 1 to Asset Purchase Agreement, dated October 8, 2020, by and between Fusion Pharmaceuticals Inc. and Rainier Therapeutics, Inc
Purchase Agreements
Fusion Pharmaceuticals Inc.
Biotechnology
DE
2020
Securities Purchase Agreement, dated May 10, 2023, by and among Fusion Pharmaceuticals Inc. and the Investors named therein
Purchase Agreements
Fusion Pharmaceuticals Inc.
Biotechnology
NY
2023
Securities Purchase Agreement, dated February 13, 2023, by and among Fusion Pharmaceuticals Inc. and the Investors named therein
Purchase Agreements
Fusion Pharmaceuticals Inc.
Biotechnology
NY
2023
Option and Asset Purchase Agreement by and between Fusion Pharmaceuticals Inc. and RadioMedix, Inc., dated November 14, 2022
Purchase Agreements
Fusion Pharmaceuticals Inc.
Biotechnology
TX
2023
Securities Purchase Agreement, dated February 13, 2023, by and among Fusion Pharmaceuticals Inc. and the Investors named therein
Purchase Agreements
Fusion Pharmaceuticals Inc.
Biotechnology
NY
2023
Option and Asset Purchase Agreement by and between Fusion Pharmaceuticals Inc. and RadioMedix, Inc., dated November 14, 2022
Purchase Agreements
Fusion Pharmaceuticals Inc.
Biotechnology
TX
2023
Amendment No. 2 to Asset Purchase Agreement, dated February 8, 2021, by and between Rainier Therapeutics, Inc. and the Company
Purchase Agreements
Fusion Pharmaceuticals Inc.
Biotechnology
2021
Asset Purchase Agreement by and between Fusion Pharmaceuticals Inc. and Ipsen Pharma SAS, dated March 1, 2021
Purchase Agreements
Fusion Pharmaceuticals Inc.
Biotechnology
NY
2021
Asset Purchase Agreement, dated as of March 10, 2020, by and between Rainier Therapeutics, Inc., Fortis Advisors LLC and the Registrant
Purchase Agreements
Fusion Pharmaceuticals Inc.
Biotechnology
NY
2020